KPMA proposes to institutionalize ex post facto drug management rules

Published: 2002-08-27 06:59:00

Updated: 2002-08-27 06:59:00

The Korea Pharmaceutical Manufacturers Association (KPMA) said it would propose its ex post facto drug management rules to the government, to this effect that the minimum drug-pricing system should be applied to the direct transaction of pharmaceutical firms, while pharmaceutical firms suffer min...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK